Aditya Vision Limited (NSE:AVL)
India · Delayed Price · Currency is INR 440.85
+23.60 (5.66%)
At close: Aug 13, 2025, 3:30 PM IST
Sage Therapeutics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 23,112 | 22,598 | 17,433 | 13,222 | 8,991 | 7,480 | Upgrade | |
Revenue Growth (YoY) | 16.09% | 29.63% | 31.85% | 47.06% | 20.20% | -6.15% | Upgrade |
Cost of Revenue | 19,473 | 19,047 | 14,655 | 11,112 | 7,567 | 6,561 | Upgrade |
Gross Profit | 3,640 | 3,551 | 2,778 | 2,110 | 1,424 | 918.82 | Upgrade |
Selling, General & Admin | 1,513 | 1,470 | 1,078 | 780.08 | 593.55 | 385.02 | Upgrade |
Operating Expenses | 1,893 | 1,840 | 1,364 | 984.32 | 754.13 | 513.23 | Upgrade |
Operating Income | 1,746 | 1,711 | 1,413 | 1,126 | 670.03 | 405.58 | Upgrade |
Interest Expense | -337.8 | -317 | -387.64 | -295.06 | -253.18 | -170.12 | Upgrade |
Interest & Investment Income | 77.78 | 77.78 | 65.25 | 28.59 | 14.44 | 18.32 | Upgrade |
Other Non Operating Income (Expenses) | 0.4 | - | - | - | 0.13 | - | Upgrade |
EBT Excluding Unusual Items | 1,487 | 1,471 | 1,091 | 859.14 | 431.42 | 253.79 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 0.46 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -40.15 | -40.15 | -24.34 | 0.3 | - | - | Upgrade |
Other Unusual Items | - | - | - | - | - | 19.47 | Upgrade |
Pretax Income | 1,447 | 1,431 | 1,067 | 859.89 | 431.42 | 273.26 | Upgrade |
Income Tax Expense | 370.93 | 376.23 | 295.97 | 218.46 | 78.6 | 68.77 | Upgrade |
Net Income | 1,076 | 1,055 | 770.7 | 641.43 | 352.82 | 204.49 | Upgrade |
Net Income to Common | 1,076 | 1,055 | 770.7 | 641.43 | 352.82 | 204.49 | Upgrade |
Net Income Growth | 16.01% | 36.88% | 20.15% | 81.80% | 72.54% | 45.85% | Upgrade |
Shares Outstanding (Basic) | 129 | 129 | 121 | 120 | 120 | 120 | Upgrade |
Shares Outstanding (Diluted) | 129 | 129 | 122 | 120 | 120 | 120 | Upgrade |
Shares Change (YoY) | 3.98% | 5.95% | 1.41% | 0.01% | - | -14.75% | Upgrade |
EPS (Basic) | 8.37 | 8.21 | 6.37 | 5.33 | 2.93 | 1.70 | Upgrade |
EPS (Diluted) | 8.33 | 8.16 | 6.32 | 5.33 | 2.93 | 1.70 | Upgrade |
EPS Growth | 11.53% | 29.11% | 18.53% | 81.79% | 72.53% | 71.09% | Upgrade |
Free Cash Flow | - | -779.18 | -406.01 | -127.44 | 134.61 | 6.87 | Upgrade |
Free Cash Flow Per Share | - | -6.03 | -3.33 | -1.06 | 1.12 | 0.06 | Upgrade |
Dividend Per Share | - | 1.100 | 0.900 | 0.750 | 0.600 | 0.500 | Upgrade |
Dividend Growth | - | 22.22% | 20.00% | 25.00% | 20.00% | 100.00% | Upgrade |
Gross Margin | 15.75% | 15.71% | 15.93% | 15.96% | 15.84% | 12.28% | Upgrade |
Operating Margin | 7.56% | 7.57% | 8.11% | 8.51% | 7.45% | 5.42% | Upgrade |
Profit Margin | 4.66% | 4.67% | 4.42% | 4.85% | 3.92% | 2.73% | Upgrade |
Free Cash Flow Margin | - | -3.45% | -2.33% | -0.96% | 1.50% | 0.09% | Upgrade |
EBITDA | 1,829 | 1,791 | 1,486 | 1,179 | 705.92 | 428.38 | Upgrade |
EBITDA Margin | 7.92% | 7.93% | 8.53% | 8.92% | 7.85% | 5.73% | Upgrade |
D&A For EBITDA | 82.91 | 80.9 | 72.89 | 53.35 | 35.89 | 22.8 | Upgrade |
EBIT | 1,746 | 1,711 | 1,413 | 1,126 | 670.03 | 405.58 | Upgrade |
EBIT Margin | 7.56% | 7.57% | 8.11% | 8.51% | 7.45% | 5.42% | Upgrade |
Effective Tax Rate | 25.64% | 26.29% | 27.75% | 25.41% | 18.22% | 25.17% | Upgrade |
Revenue as Reported | 23,190 | 22,676 | 17,498 | 13,252 | 9,006 | 7,518 | Upgrade |
Advertising Expenses | - | 225.24 | 118.58 | 86.7 | 82.67 | 60.18 | Upgrade |
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.